BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17158868)

  • 21. Activation-induced tumor necrosis factor receptor-associated factor 3 (Traf3) alternative splicing controls the noncanonical nuclear factor κB pathway and chemokine expression in human T cells.
    Michel M; Wilhelmi I; Schultz AS; Preussner M; Heyd F
    J Biol Chem; 2014 May; 289(19):13651-60. PubMed ID: 24671418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor.
    Sanjo H; Zajonc DM; Braden R; Norris PS; Ware CF
    J Biol Chem; 2010 May; 285(22):17148-55. PubMed ID: 20348096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling.
    Kanno Y; Sakurai D; Hase H; Kojima H; Kobata T
    J Recept Signal Transduct Res; 2010 Apr; 30(2):121-32. PubMed ID: 20184394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma.
    Li MY; Chong LC; Duns G; Lytle A; Woolcock B; Jiang A; Telenius A; Ben-Neriah S; Nawaz W; Slack GW; Elisia I; Viganò E; Aoki T; Healy S; Krystal G; Venturutti L; Scott DW; Steidl C
    Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2320421121. PubMed ID: 38662551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noncanonical NF-κB activation by the oncoprotein Tio occurs through a nonconserved TRAF3-binding motif.
    de Jong SJ; Albrecht JC; Giehler F; Kieser A; Sticht H; Biesinger B
    Sci Signal; 2013 Apr; 6(272):ra27. PubMed ID: 23612708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.
    Keats JJ; Fonseca R; Chesi M; Schop R; Baker A; Chng WJ; Van Wier S; Tiedemann R; Shi CX; Sebag M; Braggio E; Henry T; Zhu YX; Fogle H; Price-Troska T; Ahmann G; Mancini C; Brents LA; Kumar S; Greipp P; Dispenzieri A; Bryant B; Mulligan G; Bruhn L; Barrett M; Valdez R; Trent J; Stewart AK; Carpten J; Bergsagel PL
    Cancer Cell; 2007 Aug; 12(2):131-44. PubMed ID: 17692805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
    Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
    J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The NF-κB subunit RelB controls p100 processing by competing with the kinases NIK and IKK1 for binding to p100.
    Fusco AJ; Mazumder A; Wang VY; Tao Z; Ware C; Ghosh G
    Sci Signal; 2016 Sep; 9(447):ra96. PubMed ID: 27678221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
    Cherry EM; Lee DW; Jung JU; Sitcheran R
    Mol Cancer; 2015 Jan; 14(1):9. PubMed ID: 25622756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methods to assess the activation of the alternative (noncanonical) NF-κB pathway by non-death TNF receptors.
    Remouchamps C; Dejardin E
    Methods Mol Biol; 2015; 1280():103-19. PubMed ID: 25736746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation.
    He L; Grammer AC; Wu X; Lipsky PE
    J Biol Chem; 2004 Dec; 279(53):55855-65. PubMed ID: 15383523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling.
    Allen IC; Wilson JE; Schneider M; Lich JD; Roberts RA; Arthur JC; Woodford RM; Davis BK; Uronis JM; Herfarth HH; Jobin C; Rogers AB; Ting JP
    Immunity; 2012 May; 36(5):742-54. PubMed ID: 22503542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus latent membrane protein 1 modulates distinctive NF- kappaB pathways through C-terminus-activating region 1 to regulate epidermal growth factor receptor expression.
    Kung CP; Raab-Traub N
    J Virol; 2010 Jul; 84(13):6605-14. PubMed ID: 20410275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK.
    Zarnegar BJ; Wang Y; Mahoney DJ; Dempsey PW; Cheung HH; He J; Shiba T; Yang X; Yeh WC; Mak TW; Korneluk RG; Cheng G
    Nat Immunol; 2008 Dec; 9(12):1371-8. PubMed ID: 18997794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanding the Interactome of the Noncanonical NF-κB Signaling Pathway.
    Willmann KL; Sacco R; Martins R; Garncarz W; Krolo A; Knapp S; Bennett KL; Boztug K
    J Proteome Res; 2016 Sep; 15(9):2900-2909. PubMed ID: 27416764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TNF receptor-associated factor 1 is a positive regulator of the NF-kappaB alternative pathway.
    Lavorgna A; De Filippi R; Formisano S; Leonardi A
    Mol Immunol; 2009 Oct; 46(16):3278-82. PubMed ID: 19698991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism.
    Yao Z; Xing L; Boyce BF
    J Clin Invest; 2009 Oct; 119(10):3024-34. PubMed ID: 19770515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.
    Annunziata CM; Davis RE; Demchenko Y; Bellamy W; Gabrea A; Zhan F; Lenz G; Hanamura I; Wright G; Xiao W; Dave S; Hurt EM; Tan B; Zhao H; Stephens O; Santra M; Williams DR; Dang L; Barlogie B; Shaughnessy JD; Kuehl WM; Staudt LM
    Cancer Cell; 2007 Aug; 12(2):115-30. PubMed ID: 17692804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif.
    Darnay BG; Ni J; Moore PA; Aggarwal BB
    J Biol Chem; 1999 Mar; 274(12):7724-31. PubMed ID: 10075662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNFα induced noncanonical NF-κB activation is attenuated by RIP1 through stabilization of TRAF2.
    Kim JY; Morgan M; Kim DG; Lee JY; Bai L; Lin Y; Liu ZG; Kim YS
    J Cell Sci; 2011 Feb; 124(Pt 4):647-56. PubMed ID: 21266470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.